Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 237 articles: HTML format

Single Articles

January 2026
1. WEINTRAUB WS, Boden WE
   Does post-surgery cardiology evaluation improve clinical outcome in patients with a peri-operative myocardial infarction?
   Eur Heart J. 2026 Jan 30:ehaf1073. doi: 10.1093/eurheartj/ehaf1073.
   PubMed    
   
   
   
2. GLARNER N, Puelacher C, Gualandro DM, Pargger M, et al
   Peri-operative myocardial infarction/injury after non-cardiac surgery: association between cardiologist evaluation and outcomes.
   Eur Heart J. 2026 Jan 30:ehaf846. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. TEPPO K, Airaksinen KEJ, Vasankari T, Linko-Parvinen A, et al
   Long forms of cardiac troponin T for myocardial infarction diagnosis: the SuperTROPO study.
   Eur Heart J. 2026;47:490-499.
   PubMed     Abstract available
   
   
   
4. SAVONITTO S, Alpert JS, Thiele H, Campo G, et al
   Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.
   Eur Heart J. 2026;47:423-437.
   PubMed     Abstract available
   
   
   
5. VON SCHEIDT M, Adkar SS, Krefting J, Hoermann G, et al
   Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease.
   Eur Heart J. 2026;47:453-469.
   PubMed     Abstract available
   
   
   
6. REHMAN MB, Bjornson E, Adiels M, Morze J, et al
   Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease.
   Eur Heart J. 2026 Jan 22:ehaf1124. doi: 10.1093/eurheartj/ehaf1124.
   PubMed     Abstract available
   
   
   
7. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
   Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trial.
   Eur Heart J. 2026 Jan 6:ehaf924. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. GVOZDEVA A, Zakiev V, Ushakova O
   The beneficial effect of heart rate-lowering therapy on mortality in post-myocardial infarction patients across the treatment eras.
   Eur Heart J. 2026 Jan 6:ehaf1052. doi: 10.1093/eurheartj/ehaf1052.
   PubMed    
   
   
   
9. SANIDAS E, Michalopoulou H, Thomopoulos C
   Beta-blockers in post-myocardial infarction patients: refractive errors in reading the evidence.
   Eur Heart J. 2026 Jan 6:ehaf1053. doi: 10.1093/eurheartj/ehaf1053.
   PubMed    
   
   
   December 2025
10. BERRY C, Stanley B, Duklas P, Layland J, et al
    Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trial.
    Eur Heart J. 2025 Dec 8:ehaf925. doi: 10.1093.
    PubMed    
    
    
    
11. VOLLEBERG RHJA, Luttikholt TJ, van der Waerden RGA, Cancian P, et al
    Artificial intelligence-based identification of thin-cap fibroatheromas and clinical outcomes: the PECTUS-AI study.
    Eur Heart J. 2025;46:5032-5041.
    PubMed     Abstract available
    
    
    
12. ANDERSEN MH, Jensen JM, Kanstrup H, Sand NPR, et al
    Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry.
    Eur Heart J. 2025;46:5062-5072.
    PubMed     Abstract available
    
    
    
13. KIRMES K, Han J, Klug M, Bloxham CJ, et al
    Reticulated platelets in coronary artery disease: a multidimensional approach unveils prothrombotic signalling and novel therapeutic targets.
    Eur Heart J. 2025;46:4901-4917.
    PubMed     Abstract available
    
    
    November 2025
14. ZHANG L, Zhang YL, Ding D
    Immune checkpoint inhibitor-associated acute myocardial infarction: a case report.
    Eur Heart J. 2025 Nov 28:ehaf987. doi: 10.1093.
    PubMed    
    
    
    
15. MOHIADDIN H, Sze S, Damluji AA, Ladwiniec A, et al
    Frailty and long-term outcomes in younger patients with acute myocardial infarction.
    Eur Heart J. 2025 Nov 25:ehaf876. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. PEDICINO D, Volpe M
    Weekly Journal Scan: Reshaping the boundaries of beta-blocker use after acute myocardial infarction beyond reduced ejection fraction?
    Eur Heart J. 2025 Nov 18:ehaf856. doi: 10.1093.
    PubMed    
    
    
    
17. DUNCKER D, Marijon E, Metra M, Piot O, et al
    Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study.
    Eur Heart J. 2025;46:4597-4606.
    PubMed     Abstract available
    
    
    
18. ZHANG B, Yang J, Ge J
    First myocardial infarction: incorporating non-traditional risk factors to bridge the prevention gap.
    Eur Heart J. 2025 Nov 11:ehaf851. doi: 10.1093.
    PubMed    
    
    
    
19. VERGALLO R, Patrono C
    Weekly Journal Scan: Ischaemic vs bleeding risk early after myocardial infarction-which should we TARGET FIRST?
    Eur Heart J. 2025 Nov 11:ehaf893. doi: 10.1093.
    PubMed    
    
    
    
20. NURMOHAMED NS, Bhatt DL
    Preventing the first myocardial infarction: from reaction to action.
    Eur Heart J. 2025 Nov 11:ehaf852. doi: 10.1093.
    PubMed    
    
    
    
21. BOERHOUT CKM, Namba HF, Liu T, Beijk MAM, et al
    Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial.
    Eur Heart J. 2025;46:4396-4406.
    PubMed     Abstract available
    
    
    October 2025
22. AYYAD M, Albandak M, Allencherril J
    Reclassifying myocardial infarction: from ST elevation to coronary occlusion.
    Eur Heart J. 2025 Oct 30:ehaf825. doi: 10.1093.
    PubMed    
    
    
    
23. MONTONE RA, Cosentino N, Gorla R, Biscaglia S, et al
    Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial.
    Eur Heart J. 2025 Oct 28:ehaf917. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. LOMBARDI M, Boivin-Proulx LA, Jeronimo A, Mejia-Renteria H, et al
    Angina after percutaneous coronary interventions.
    Eur Heart J. 2025 Oct 17:ehaf771. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. CREA F
    Ischaemic heart disease: changing landscape of risk stratification, importance of coronary stenosis functional assessment, optimal timing of anticoagulation in ST elevation myocardial infarction.
    Eur Heart J. 2025;46:3799-3804.
    PubMed    
    
    
    
26. ARAI R, Kojima K, Fukamachi D, Okumura Y, et al
    DanGer shock criteria and outcomes in acute myocardial infarction-related cardiogenic shock treated with Impella: the J-PVAD registry.
    Eur Heart J. 2025 Oct 13:ehaf787. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. VERGALLO R, Pedicino D
    Weekly Journal Scan: An integrated rehabilitation strategy after myocardial infarction in older patients with impaired physical performance.
    Eur Heart J. 2025 Oct 9:ehaf780. doi: 10.1093.
    PubMed    
    
    
    
28. MEENA D, Huang J, Smith A, Yarmolinsky J, et al
    Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study.
    Eur Heart J. 2025 Oct 9:ehaf725. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. DE SILVA R, Cheng K, Henry TD, Perera D, et al
    Refractory angina: mechanisms and stratified treatment in obstructive and non-obstructive chronic myocardial ischaemic syndromes.
    Eur Heart J. 2025;46:3738-3757.
    PubMed     Abstract available
    
    
    September 2025
30. MUELLER C, White HD, Lopez-Ayala P, de Silva R, et al
    Great debate: the universal definition of myocardial infarction is flawed and should be put to rest.
    Eur Heart J. 2025 Sep 9:ehaf641. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. 
    Correction to: Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
    Eur Heart J. 2025 Sep 8:ehaf708. doi: 10.1093.
    PubMed    
    
    
    
32. GIRAUD MN
    Macrophage leukotriene B4 production sustains inflammation after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf471. doi: 10.1093.
    PubMed    
    
    
    
33. CHEN Z, Song J, Feng S, Liu M, et al
    Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf493. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. AMICONE S, Fedele D, Pizzi C
    Revascularization in latecomer ST-elevation myocardial infarction patients: diverging ACC/AHA and ESC Guidelines.
    Eur Heart J. 2025 Sep 3:ehaf616. doi: 10.1093.
    PubMed    
    
    
    
35. GOULD KL, Johnson NP, Roby AE, Kirkeeide R, et al
    Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.
    Eur Heart J. 2025;46:3273-3286.
    PubMed     Abstract available
    
    
    August 2025
36. ROSSELLO X, Dominguez-Rodriguez A, Latini R, Sanchez PL, et al
    Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.
    Eur Heart J. 2025 Aug 30:ehaf673. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. KAWAGUCHI N, Ando R, Obata J
    A case of cardiopulmonary arrest on arrival due to acute myocardial infarction with immunoglobulin G4-related coronary periarteritis.
    Eur Heart J. 2025 Aug 29:ehaf632. doi: 10.1093.
    PubMed    
    
    
    
38. MANGIACAPRA F, Paolucci L, De Bruyne B, Rioufol G, et al
    Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
    Eur Heart J. 2025 Aug 20:ehaf504. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. LI F, Flynn E, Ha P, Zebak MN, et al
    LIPA, a risk locus for coronary artery disease: decoding the variant-to-function relationship.
    Eur Heart J. 2025 Aug 19:ehaf581. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. KRALER S, Mueller C, Libby P, Bhatt DL, et al
    Acute coronary syndromes: mechanisms, challenges, and new opportunities.
    Eur Heart J. 2025;46:2866-2889.
    PubMed     Abstract available
    
    
    
41. CHEN J, Xu C, Qiu L, Li B, et al
    Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.
    Eur Heart J. 2025 Aug 1:ehaf481. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
42. 
    Correction to: Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Jul 31:ehaf579. doi: 10.1093.
    PubMed    
    
    
    
43. PARADIES V, Masiero G, Rubboli A, Van Beusekom HMM, et al
    Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Eur Heart J. 2025;46:2730-2741.
    PubMed     Abstract available
    
    
    
44. MORZE J, Melloni GEM, Wittenbecher C, Ala-Korpela M, et al
    ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease.
    Eur Heart J. 2025;46:2691-2701.
    PubMed     Abstract available
    
    
    
45. 
    Correction to: Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
    Eur Heart J. 2025 Jul 10:ehaf510. doi: 10.1093.
    PubMed    
    
    
    
46. FEZZI S, Scheller B, Cortese B, Alfonso F, et al
    Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
    Eur Heart J. 2025;46:2498-2519.
    PubMed     Abstract available
    
    
    
47. NURMOHAMED NS, Ngo-Metzger Q, Taub PR, Ray KK, et al
    First myocardial infarction: risk factors, symptoms, and medical therapy.
    Eur Heart J. 2025 Jul 3:ehaf390. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
48. MILLER RJH, Yi J, Shanbhag A, Marcinkiewicz A, et al
    Deep learning-quantified body composition from positron emission tomography/computed tomography and cardiovascular outcomes: a multicentre study.
    Eur Heart J. 2025;46:2336-2347.
    PubMed     Abstract available
    
    
    
49. WANG S, Luo X, Hu S, Zhao C, et al
    Plaque erosion risk and JAK2 V617F variant.
    Eur Heart J. 2025;46:2205-2219.
    PubMed     Abstract available
    
    
    
50. WANG X, Xu Y, Yu C, Deng R, et al
    Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils.
    Eur Heart J. 2025;46:2223-2238.
    PubMed     Abstract available
    
    
    
51. TOVAL A, Bakker EA, Granada-Maia JB, Nunez de Arenas-Arroyo S, et al
    Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis.
    Eur Heart J. 2025;46:2186-2201.
    PubMed     Abstract available
    
    
    
52. ZEDER K, Mak S, Galie N, Rosenkranz S, et al
    Right heart catheterization in heart failure: indications, interpretation, and pitfalls.
    Eur Heart J. 2025 Jun 16:ehaf322. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. HASSAN IN, Ashraf H, Hasan A
    Sudan conflict: impact on interrupted care after acute myocardial infarction.
    Eur Heart J. 2025 Jun 12:ehaf313. doi: 10.1093.
    PubMed    
    
    
    
54. ARENAS-MONTES J, Alcala-Diaz JF, Garcia-Fernandez H, Gutierrez-Mariscal FM, et al
    A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study.
    Eur Heart J. 2025;46:2104-2115.
    PubMed     Abstract available
    
    
    
55. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
    Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
    Eur Heart J. 2025;46:2052-2062.
    PubMed     Abstract available
    
    
    
56. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
    Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
    Eur Heart J. 2025;46:2092-2100.
    PubMed     Abstract available
    
    
    
57. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
    Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
    Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
58. KIM MC, Park SJ, Park DW, Ahn JM, et al
    Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
    Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. PROCOPI N, Zeitouni M, Kerneis M, Cayla G, et al
    Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
    Eur Heart J. 2025 May 22:ehaf170. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. CLELAND JGF
    Staring into the AbetaYSS: how many pills and for how long after myocardial infarction?
    Eur Heart J. 2025 May 22:ehaf226. doi: 10.1093.
    PubMed    
    
    
    
61. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
    Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. COYLE M, McEvoy JW
    Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction.
    Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093.
    PubMed    
    
    
    
63. WANG J, Verkerk AO, Wilders R, Zhang Y, et al
    SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
    Eur Heart J. 2025;46:1747-1762.
    PubMed     Abstract available
    
    
    
64. PERRY CGR, Sweeney G
    Targeting mitochondrial fission for the treatment of myocardial infarction.
    Eur Heart J. 2025 May 6:ehaf296. doi: 10.1093.
    PubMed    
    
    
    
65. OIKONOMOU G, Cheng K, Mohiaddin RH
    CMR: a gatekeeper before ICA in a stable non ST-elevation myocardial infarction patient with severely impaired LV function.
    Eur Heart J. 2025 May 6:ehaf300. doi: 10.1093.
    PubMed    
    
    
    
66. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    PubMed     Abstract available
    
    
    
67. WEYRICH M, Zewinger S, Sarakpi T, Rasper T, et al
    Mosaic loss of Y chromosome and mortality after coronary angiography.
    Eur Heart J. 2025;46:1603-1616.
    PubMed     Abstract available
    
    
    
68. ZHANG Q, Li H, Zhuang T, Xu L, et al
    CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
    Eur Heart J. 2025;46:1645-1658.
    PubMed     Abstract available
    
    
    
69. D'ENTREMONT MA, Poorthuis MHF, Fiolet ATL, Amarenco P, et al
    Colchicine for secondary prevention of vascular events: a meta-analysis of trials.
    Eur Heart J. 2025 May 2:ehaf210. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. SAMUEL M, Berry C, Dube MP, Koenig W, et al
    Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.
    Eur Heart J. 2025 May 2:ehaf174. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
71. CREA F
    Focus on heart failure: sex-related differences, new light shed on SGLT2i mechanism of action, and heart failure after myocardial infarction.
    Eur Heart J. 2025;46:1457-1461.
    PubMed    
    
    
    
72. MOLLER JE, Thiele H, Morrow D, Kjaergaard J, et al
    Mechanical circulatory support: when, how, and for whom.
    Eur Heart J. 2025;46:1480-1492.
    PubMed     Abstract available
    
    
    
73. CHEN J, Zhao J, Fu S
    Addressing sample overlap and meta-analysis imbalances in Mendelian randomization: a critical appraisal of protein targets for myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf186. doi: 10.1093.
    PubMed    
    
    
    
74. TITOVA OE, Yuan S, Larsson SC
    Applying Mendelian randomization to study the relationship between circulating proteins and myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf187. doi: 10.1093.
    PubMed    
    
    
    
75. BAY B, Tanner R, Gao M, Oliva A, et al
    Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
    Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. BOUGHANEM H, Herrero-Cervera A, Soehnlein O
    SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction repair.
    Eur Heart J. 2025 Apr 8:ehaf165. doi: 10.1093.
    PubMed    
    
    
    March 2025
77. CHIU IM, Ouyang D
    Acute myocardial infarction diagnosis: impact of artificial intelligence-powered ECG interpretation.
    Eur Heart J. 2025 Mar 25:ehaf142. doi: 10.1093.
    PubMed    
    
    
    
78. SOUZA ACDAH, Troschel AS, Marquardt JP, Hadzic I, et al
    Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes.
    Eur Heart J. 2025;46:1112-1123.
    PubMed     Abstract available
    
    
    
79. XU Y, Feng T, Huang Y
    Gender-specific associations and circulating proteins in myocardial infarction: potential causal relationships.
    Eur Heart J. 2025 Mar 7:ehaf111. doi: 10.1093.
    PubMed    
    
    
    
80. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Circulating proteins and incident myocardial infarction: appraising sex-specific differences and causality.
    Eur Heart J. 2025 Mar 7:ehaf113. doi: 10.1093.
    PubMed    
    
    
    
81. BOUZID Z, Sejdic E, Martin-Gill C, Faramand Z, et al
    Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome.
    Eur Heart J. 2025;46:943-954.
    PubMed     Abstract available
    
    
    
82. CLAESSEN G, Eijsvogels TMH, Albert CM, Baggish AL, et al
    Coronary atherosclerosis in athletes: emerging concepts and preventive strategies.
    Eur Heart J. 2025;46:890-903.
    PubMed     Abstract available
    
    
    
83. CALAFIORE AM, Prapas S, Gaudino M
    Arterial conduits for coronary bypass grafting: the set-point concept.
    Eur Heart J. 2025;46:922-925.
    PubMed     Abstract available
    
    
    
84. DANG QM, Psaltis PJ, Burgess S, Chandrasekhar J, et al
    The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.
    Eur Heart J. 2025 Mar 7:ehaf097. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
85. LEE MS, Shin TG, Lee Y, Kim DH, et al
    Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study.
    Eur Heart J. 2025 Feb 24:ehaf004. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. CHEN G, Gan J, Wu F, Zhou Z, et al
    Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Feb 11:ehaf032. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. SQUIRE IB, Sze S
    Prognosis following acute myocardial infarction.
    Eur Heart J. 2025 Feb 10:ehaf056. doi: 10.1093.
    PubMed    
    
    
    
88. ROMAN M, Miksza J, Lai FY, Sze S, et al
    Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study.
    Eur Heart J. 2025;46:535-547.
    PubMed     Abstract available
    
    
    
89. CREA F
    Focus on the extreme of the spectrum: myocardial infarction with no obstructive coronary arteries and ischaemic cardiomyopathy.
    Eur Heart J. 2025;46:399-403.
    PubMed    
    
    
    
90. RASMUSSEN LD, Schmidt SE, Knuuti J, Vrints C, et al
    Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials.
    Eur Heart J. 2025;46:473-483.
    PubMed     Abstract available
    
    
    
91. RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al
    Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome.
    Eur Heart J. 2025;46:424-435.
    PubMed     Abstract available
    
    
    January 2025
92. BUTLER J, Hammonds K, Talha KM, Alhamdow A, et al
    Incident heart failure and recurrent coronary events following acute myocardial infarction.
    Eur Heart J. 2025 Jan 28:ehae885. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. PEDICINO D, Volpe M
    Weekly Journal Scan: A CLEAR message questions the routine use of spironolactone in acute myocardial infarction.
    Eur Heart J. 2025 Jan 21:ehae936. doi: 10.1093.
    PubMed    
    
    
    
94. REEH J, Afzal S, Wulff AB, Nordestgaard BG, et al
    Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years.
    Eur Heart J. 2025 Jan 17:ehae912. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. LIUZZO G, Patrono C
    Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction.
    Eur Heart J. 2025 Jan 9:ehae897. doi: 10.1093.
    PubMed    
    
    
    
96. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    PubMed     Abstract available
    
    
    
97. BJERKING LH, Skak-Hansen KW, Heitmann M, Hove JD, et al
    Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.
    Eur Heart J. 2025;46:117-128.
    PubMed     Abstract available
    
    
    
98. WENZL FA, Wang P, Arrigo M, Parenica J, et al
    Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score.
    Eur Heart J. 2025;46:38-54.
    PubMed     Abstract available
    
    
    December 2024
99. ZHANG Y, Yu S, Chen Z, Liu H, et al
    Gestational diabetes and future cardiovascular diseases: associations by sex-specific genetic data.
    Eur Heart J. 2024;45:5156-5167.
    PubMed     Abstract available
    
    
    
100. PEDICINO D, Volpe M
     Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial.
     Eur Heart J. 2024 Dec 14:ehae858. doi: 10.1093.
     PubMed    
     
     
     
101. CHAPMAN AR, Taggart C, Boeddinghaus J, Mills NL, et al
     Type 2 myocardial infarction: challenges in diagnosis and treatment.
     Eur Heart J. 2024 Dec 10:ehae803. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2024
102. BACK M, Hofmann R
     Myocardial infarction and low ambient temperature: does presence or absence of stenoses make a difference?
     Eur Heart J. 2024 Nov 28:ehae820. doi: 10.1093.
     PubMed    
     
     
     
103. AI L, de Freitas Germano J, Huang C, Aniag M, et al
     Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.
     Eur Heart J. 2024 Nov 27:ehae782. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
     Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
     Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. NARAYANAN S, Vuckovic S, Bergman O, Wirka R, et al
     Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.
     Eur Heart J. 2024 Nov 18:ehae768. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. BENDRISS E, Pasqueron J, Bardon J
     Coronary air embolism causing myocardial infarction following a blunt chest trauma.
     Eur Heart J. 2024 Nov 14:ehae771. doi: 10.1093.
     PubMed    
     
     
     
107. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
     Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
     Eur Heart J. 2024;45:4564-4578.
     PubMed     Abstract available
     
     
     
108. ZURIAGA MA, Yu Z, Matesanz N, Truong B, et al
     Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis.
     Eur Heart J. 2024;45:4601-4615.
     PubMed     Abstract available
     
     
     
109. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
     Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
     Eur Heart J. 2024;45:4630-4643.
     PubMed     Abstract available
     
     
     October 2024
110. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
     Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
     Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. HUANG J, He Q, Jiang Y, Wong JMJ, et al
     Low ambient temperature and incident myocardial infarction with or without obstructive coronary arteries: a Chinese nationwide study.
     Eur Heart J. 2024 Oct 28:ehae711. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. KANG D, Choi KH, Kim H, Park H, et al
     Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
     Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
     Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
     Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
     Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
     Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
     PubMed    
     
     
     
115. LIUZZO G, Patrono C
     Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?
     Eur Heart J. 2024 Oct 18:ehae684. doi: 10.1093.
     PubMed    
     
     
     
116. RAJAKULASINGAM R, Ferreira PF, Scott AD, Khalique Z, et al
     Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance.
     Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093.
     PubMed     Abstract available
     
     
     
117. CREA F
     Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets.
     Eur Heart J. 2024;45:4141-4144.
     PubMed    
     
     
     
118. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
     Plasma proteome and incident myocardial infarction: sex-specific differences.
     Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. BARTON AK, Lau ES, Gulati M
     Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction.
     Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093.
     PubMed    
     
     
     
120. DESCH S, Zeymer U, Akin I, Behnes M, et al
     Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial.
     Eur Heart J. 2024;45:4200-4203.
     PubMed    
     
     
     
121. WEINTRAUB WS, Boden WE
     Achieving successful prevention of coronary artery disease: a worldwide call to action.
     Eur Heart J. 2024;45:4197-4199.
     PubMed    
     
     
     
122. LUSEBRINK E, Binzenhofer L, Thiele H
     The DanGer Shock trial: a new dawn but much to uncover.
     Eur Heart J. 2024;45:4181-4183.
     PubMed    
     
     
     
123. LUSCHER TF, Thiele H
     Cardiogenic shock: do we need a paradigm shift?
     Eur Heart J. 2024;45:4178-4180.
     PubMed    
     
     
     
124. 
     Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
     Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
     PubMed    
     
     
     
125. AJUFO EC, Tedrow UB
     Refining the stratification of sudden cardiac death risk after myocardial infarction-beyond ejection fraction.
     Eur Heart J. 2024 Oct 8:ehae272. doi: 10.1093.
     PubMed    
     
     
     
126. PEEK N, Hindricks G, Akbarov A, Tijssen JGP, et al
     Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
     Eur Heart J. 2024 Oct 8:ehae326. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. SHIMADA T, Fujisawa N, Otsuka K
     Intracoronary polarimetric signatures of exercise-induced vasospastic angina.
     Eur Heart J. 2024;45:3894.
     PubMed    
     
     
     September 2024
128. XU Y, Li H, Santosa A, Wettermark B, et al
     Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study.
     Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. CREA F
     New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
     Eur Heart J. 2024;45:3299-3302.
     PubMed    
     
     
     
130. BAIREY MERZ CN
     Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure.
     Eur Heart J. 2024;45:3748-3750.
     PubMed    
     
     
     
131. BODEN WE, De Caterina R, Kaski JC, Bairey Merz N, et al
     Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.
     Eur Heart J. 2024;45:3701-3706.
     PubMed     Abstract available
     
     
     
132. VRINTS C, Andreotti F, Koskinas KC, Rossello X, et al
     2024 ESC Guidelines for the management of chronic coronary syndromes.
     Eur Heart J. 2024;45:3415-3537.
     PubMed    
     
     
     
133. NURMOHAMED NS, Min JK, Anthopolos R, Reynolds HR, et al
     Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
     Eur Heart J. 2024;45:3735-3747.
     PubMed     Abstract available
     
     
     
134. VERGALLO R, Liuzzo G
     Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease.
     Eur Heart J. 2024;45:3311-3313.
     PubMed    
     
     
     
135. PEDICINO D, Volpe M
     Weekly Journal Scan: increased incidence of acute myocardial infarction in patients with laboratory-confirmed influenza infection.
     Eur Heart J. 2024 Sep 25:ehae569. doi: 10.1093.
     PubMed    
     
     
     
136. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
     Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
     Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
     Great debate: myocardial infarction after cardiac surgery must be redefined.
     Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
     PubMed    
     
     
     
138. BADIMON L, Kiss A, Podesser BK
     Spleen in action for cardioprotection.
     Eur Heart J. 2024;45:3178-3180.
     PubMed    
     
     
     
139. NISHI T, Kume T, Saito Y, Kato K, et al
     Intraplaque haemorrhage, coronary spasm, and resuscitated cardiac arrest in patients with non-obstructive coronary artery disease.
     Eur Heart J. 2024;45:3181-3183.
     PubMed    
     
     
     
140. LIUZZO G, Patrono C
     Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
     Eur Heart J. 2024;45:3108-3110.
     PubMed    
     
     
     
141. LIEDER HR, Paket U, Skyschally A, Rink AD, et al
     Vago-splenic signal transduction of cardioprotection in humans.
     Eur Heart J. 2024;45:3164-3177.
     PubMed     Abstract available
     
     
     
142. GIBSON CM, Duffy D, Bahit MC, Chi G, et al
     Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
     Eur Heart J. 2024 Sep 2:ehae614. doi: 10.1093.
     PubMed     Abstract available
     
     
     
143. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
     Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
     Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
     PubMed     Abstract available
     
     
     
144. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
     Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
     Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
     Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
     Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. EITEL I, Saraei R, Jurczyk D, Fach A, et al
     Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
     Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. SCHUBERT J, Leosdottir M, Lindahl B, Westerberg J, et al
     Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.
     Eur Heart J. 2024 Sep 1:ehae576. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. VAN DEN BROEK WWA, Ten Berg JM
     The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
     Eur Heart J. 2024;45:3057-3059.
     PubMed    
     
     
     
149. PRENDERGAST BD, Patterson T, Redwood S
     Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
     Eur Heart J. 2024;45:3042-3044.
     PubMed    
     
     
     August 2024
150. ONDRACEK AS, Afonyushkin T, Aszlan A, Taqi S, et al
     Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.
     Eur Heart J. 2024 Aug 31:ehae584. doi: 10.1093.
     PubMed    
     
     
     
151. GERHARDT T, Landmesser U
     Malondialdehyde-specific natural IgM inhibit NETosis triggered by coronary extracellular vesicles of myocardial infarction patients.
     Eur Heart J. 2024 Aug 31:ehae554. doi: 10.1093.
     PubMed    
     
     
     
152. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
     Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
     Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. 
     Correction to: Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
     Eur Heart J. 2024 Aug 30:ehae581. doi: 10.1093.
     PubMed    
     
     
     
154. MCEVOY JW, Jennings C, Kotseva K, De Bacquer D, et al
     Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.
     Eur Heart J. 2024 Aug 30:ehae558. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. TARDIF JC, Ouellette K, Boulet J
     Colchicine improves outcomes in coronary disease, but will it in heart failure?
     Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093.
     PubMed    
     
     
     
156. MAHAFFEY KW, Tuttle KR, Arici M, Baeres FMM, et al
     Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.
     Eur Heart J. 2024 Aug 30:ehae613. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. CREA F
     Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
     Eur Heart J. 2024;45:2795-2799.
     PubMed    
     
     
     
158. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
     Coronary artery disease management in older adults: revascularization and exercise training.
     Eur Heart J. 2024;45:2811-2823.
     PubMed     Abstract available
     
     
     
159. CREA F
     Heart failure and ischaemic heart disease: new challenges and opportunities.
     Eur Heart J. 2024;45:2681-2685.
     PubMed    
     
     
     
160. BURZOTTA F, Zito A, Aurigemma C, Romagnoli E, et al
     Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial.
     Eur Heart J. 2024;45:2785-2788.
     PubMed    
     
     
     
161. VOLLEBERG R, Damman P, van Royen N
     Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography.
     Eur Heart J. 2024;45:2793.
     PubMed    
     
     
     
162. CIULLO A, Li L, Li C, Tsi K, et al
     Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated cardioprotection via a novel gene-methylating mechanism.
     Eur Heart J. 2024;45:2660-2673.
     PubMed     Abstract available
     
     
     
163. PEDICINO D, Vergallo R
     Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
     Eur Heart J. 2024;45:2592-2593.
     PubMed    
     
     
     July 2024
164. LIUZZO G, Patrono C
     Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction.
     Eur Heart J. 2024 Jul 26:ehae446. doi: 10.1093.
     PubMed    
     
     
     
165. BESOLA L, Colli A, De Caterina R
     Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
     Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. KANG J, Yun J, Park KW, Park M, et al
     Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
     Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. CREA F
     Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
     Eur Heart J. 2024;45:2463-2467.
     PubMed    
     
     
     
168. GIANNITSIS E, Frey N, Katus HA
     Accelerated high sensitivity troponin diagnostics: ready for an even faster pace?
     Eur Heart J. 2024;45:2516-2518.
     PubMed    
     
     
     
169. DIEZ BENAVENTE E, Sakkers TR, van der Harst P, den Ruijter HM, et al
     Atherosclerotic plaque-specific methylation biomarkers in plasma cell-free DNA of female and male patients with coronary artery disease.
     Eur Heart J. 2024;45:2468-2470.
     PubMed    
     
     
     
170. AHMAD Y, Lansky AJ
     Periprocedural myocardial infarction: thresholds of (in)significance.
     Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
     PubMed    
     
     
     
171. JURADO-ROMAN A, Agudo-Quilez P
     Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
     Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
     PubMed    
     
     
     
172. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
     Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
     Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
     PubMed     Abstract available
     
     
     
173. FIGTREE GA, Gray MP
     Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet.
     Eur Heart J. 2024;45:2407-2409.
     PubMed    
     
     
     
174. ROGER G, Ducrocq G, Mesnier J, Sayah N, et al
     Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
     Eur Heart J. 2024;45:2396-2406.
     PubMed     Abstract available
     
     
     
175. BEKKI M, Tahara N, Fukumoto Y
     Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
     Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
     PubMed    
     
     
     June 2024
176. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
     Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
     Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
     PubMed     Abstract available
     
     
     
177. VILAHUR G, Radike M, Badimon L
     Novel cardioprotective approaches in ischaemic heart disease.
     Eur Heart J. 2024;45:2109-2111.
     PubMed    
     
     
     
178. HOLFELD J, Nagele F, Polzl L, Engler C, et al
     Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
     Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
     PubMed     Abstract available
     
     
     
179. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
     Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
     Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
     PubMed     Abstract available
     
     
     
180. PEDICINO D, Volpe M
     Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?
     Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093.
     PubMed    
     
     
     
181. COUGHLAN JJ, Durand R, Byrne RA
     An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
     Eur Heart J. 2024;45:2063-2065.
     PubMed    
     
     
     
182. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
     Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
     Eur Heart J. 2024;45:2052-2062.
     PubMed     Abstract available
     
     
     
183. BEERKENS FJ, Bhatt DL
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
     Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
     PubMed    
     
     
     
184. CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al
     Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.
     Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. LIUZZO G, Patrono C
     Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
     Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093.
     PubMed    
     
     
     
186. VERGALLO R, Pedicino D
     Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
     Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093.
     PubMed    
     
     
     
187. UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al
     How artificial intelligence can assist with ischaemic heart disease.
     Eur Heart J. 2024;45:1866-1868.
     PubMed    
     
     
     May 2024
188. REN J, Bowyer A, Tian DH, Royse C, et al
     Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
     Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
     PubMed     Abstract available
     
     
     
189. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
     Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. KWON O, Ahn JH, Koh JS, Park Y, et al
     Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
     Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
     PubMed     Abstract available
     
     
     
191. CREA F
     The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease.
     Eur Heart J. 2024;45:1769-1773.
     PubMed    
     
     
     
192. NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al
     Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
     Eur Heart J. 2024;45:1783-1800.
     PubMed     Abstract available
     
     
     
193. HARIK L, Gaudino M
     Coronary angiography and bypass surgery: born together and now going separate ways?
     Eur Heart J. 2024;45:1816-1818.
     PubMed    
     
     
     
194. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
     Coronary bypass surgery guided by computed tomography in a low-risk population.
     Eur Heart J. 2024;45:1804-1815.
     PubMed     Abstract available
     
     
     
195. LEE YJ, Shin S, Kwon SW, Suh Y, et al
     Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
     Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
     PubMed     Abstract available
     
     
     
196. DVIR D, Tchetche D, Leon MB, Genereux P, et al
     Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
     Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
     Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
     Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
     PubMed     Abstract available
     
     
     
198. CREA F
     Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
     Eur Heart J. 2024;45:1577-1581.
     PubMed    
     
     
     
199. TAKAHARA M, Soga Y, Iida O
     Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
     Eur Heart J. 2024;45:1634-1643.
     PubMed     Abstract available
     
     
     
200. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
     Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
     Eur Heart J. 2024;45:1681-1683.
     PubMed    
     
     
     
201. YANG K, Gao R, Chen H, Hu J, et al
     Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
     Eur Heart J. 2024;45:1662-1680.
     PubMed     Abstract available
     
     
     
202. ADLAM D, van Dijk FS, Loeys B
     Genetic testing in patients with unexplained coronary aneurysms or dilation.
     Eur Heart J. 2024;45:1610-1612.
     PubMed    
     
     
     
203. JONES DA, Beirne AM, Kelham M, Wynne L, et al
     Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
     Eur Heart J. 2024;45:1647-1658.
     PubMed     Abstract available
     
     
     
204. XIAO Q, Xu Y, Wang S
     Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
     Eur Heart J. 2024;45:1685.
     PubMed    
     
     
     
205. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
     Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
     Eur Heart J. 2024;45:1540-1549.
     PubMed     Abstract available
     
     
     
206. HEUSCH G, Kleinbongard P
     Cardioprotection research has left its comfort zone.
     Eur Heart J. 2024;45:1568-1570.
     PubMed    
     
     
     
207. VERGALLO R, Patrono C
     Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
     Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
     PubMed    
     
     
     April 2024
208. NGO LTH, Peng Y, Denman R, Yang I, et al
     Long-term outcomes after hospitalization for atrial fibrillation or flutter.
     Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
     PubMed     Abstract available
     
     
     
209. GALIUTO L, Volpe M
     Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
     Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
     PubMed    
     
     
     
210. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
     Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
     Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
     PubMed    
     
     
     
211. VERGALLO R, Galiuto L
     Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
     Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
     PubMed    
     
     
     
212. CREA F
     The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
     Eur Heart J. 2024;45:1183-1187.
     PubMed    
     
     
     
213. KASKI JC, Al-Lamee R, Boden WE
     The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
     Eur Heart J. 2024;45:1201-1204.
     PubMed    
     
     
     
214. AMERI P, Bertero E, Lombardi M, Porto I, et al
     Ischaemic heart disease in patients with cancer.
     Eur Heart J. 2024;45:1209-1223.
     PubMed     Abstract available
     
     
     
215. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
     The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
     Eur Heart J. 2024;45:1193-1195.
     PubMed    
     
     
     
216. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
     Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
     Eur Heart J. 2024;45:1285.
     PubMed    
     
     
     
217. WU VC, Yeh JK, Chen SW, Wu CL, et al
     Syphilis and cardiovascular risk: a Taiwanese registry.
     Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
     PubMed     Abstract available
     
     
     
218. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
     Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
     Eur Heart J. 2024;45:1173-1176.
     PubMed    
     
     
     March 2024
219. LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al
     Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
     Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093.
     PubMed     Abstract available
     
     
     
220. WYLD M, Webster AC
     Myocardial infarction and stroke in patients with kidney failure: can we do better?
     Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
     PubMed    
     
     
     
221. TSUDA K, Nagamatsu W, Morii I
     A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
     Eur Heart J. 2024;45:1087.
     PubMed    
     
     
     
222. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
     Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
     Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
     PubMed     Abstract available
     
     
     
223. URSO S, Sadaba R, Dayan V
     Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
     Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
     PubMed    
     
     
     
224. VERGALLO R, Galiuto L
     Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
     Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
     PubMed    
     
     
     
225. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
     Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
     Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
     PubMed     Abstract available
     
     
     
226. CREA F
     Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
     Eur Heart J. 2024;45:637-641.
     PubMed    
     
     
     
227. JANSEN TPJ, Wentzel JJ, Damman P
     Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
     Eur Heart J. 2024;45:737.
     PubMed    
     
     
     February 2024
228. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
     Human papillomavirus infection and cardiovascular mortality: a cohort study.
     Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
     PubMed     Abstract available
     
     
     
229. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
     Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
     Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2024
230. SENIOR R, Khattar RS
     To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
     Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
     PubMed    
     
     
     
231. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
     Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
232. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
     Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
     Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
     PubMed     Abstract available
     
     
     
233. LI Z, Zhang H, Lin S
     Functionally bicuspid aortic valve leads to myocardial ischaemia.
     Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
     PubMed    
     
     
     December 2023
234. PIRIOU PG, Plessis J, Guerin P
     Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
     Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
     PubMed    
     
     
     November 2023
235. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     
236. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
     Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
     Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
     PubMed     Abstract available
     
     
     
237. KIM H, Kang DY, Lee J, Choi Y, et al
     Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
     Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.